January 9, 2005Open Access
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
Structured PICO
Does nebivolol reduce mortality and cardiovascular hospital admission in elderly patients with heart failure?
P
Population
Elderly patients with heart failure
I
Intervention
Nebivolol
O
Outcome
Mortality and cardiovascular hospital admissioncomposite
Nebivolol is an effective and well-tolerated treatment for heart failure in elderly patients.
Abstract
Nebivolol, a beta-blocker with vasodilating properties, is an effective and well-tolerated treatment for heart failure in the elderly.
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Authors
M
Marcus Flather
General Cardiology
M
Marcelo C. Shibata
University of Alberta
Andrew J.S. Coats
Heart Failure & Transplant
Journals
European Heart Journal
Actions
Institutions
Imperial College London
Sorbonne Université
The University of Sydney
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...